BIOVERATIV INC Chart calendar Bioverativ Inc
0852de7177147d7.TpuFdo27lUd0Yftqh0p3bo9xokxKWdWHRfgirOxGKvE.HMvwTtvjohYDNo0dyR0FNLwjy30ibOfxEspD59wXHbsWrdYl0tDGLDlZog~e08bb1c0fccd72bc7055b9045fed68d8
Upcoming events on Bioverativ Inc
No events available
Past events on Bioverativ Inc
| 2018-02-13 04:15 pm | FY 2017 Earnings Release |
| 2018-01-08 07:30 pm | J.P. Morgan Health Care Conference - Q&A |
| 2018-01-08 | J.P. Morgan Health Care Conference |
| 2017-12-09 | American Society of Hematology Meeting |
| 2017-11-29 10:15 am | Evercore ISI Inaugural Biopharma Catalyst/Deep Dive Conference |
| 2017-11-07 05:55 pm | Credit Suisse Health Care Conference |
| 2017-10-27 08:00 am | Q3 2017 Earnings Call |
| 2017-10-26 04:15 pm | Q3 2017 Earnings Release |
| 2017-09-06 12:00 pm | Citigroup Biotech Conference |
| 2017-08-03 08:00 am | Interim 2017 Earnings Call |
| 2017-08-02 04:31 pm | Interim 2017 Earnings Release |
| 2017-06-06 10:30 am | Jefferies Global Health Care Conference |
| 2017-05-23 08:30 am | Acquisition of True North Therapeutics by Bioverativ Inc Call |
| 2017-05-16 05:20 pm | Bank of America Merrill Lynch Health Care Conference |
| 2017-05-04 08:00 am | Q1 2017 Earnings Call |
| 2017-05-03 05:07 pm | Q1 2017 Earnings Release |
| 2017-02-15 11:00 am | Leerink Partners Global Healthcare Conference |
More events
Past sector events for Bioverativ Inc
| 2024-05-03 07:00 am | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:02 pm | ARDELYX, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-02 04:00 pm | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 2024-05-02 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | GERON CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
